Location: Home
  • search
  • go
  • Relate News
  • 10/6/2009Sandoz launches first biosimilar in Japan
  • 10/5/2009NDRC issues retail guidance prices for national essential drugs
  • 10/5/2009Growth of Chinese pharma industry slowed slightly in the first eight m...
  • 10/5/2009Chinese government conditionally approves Pfizer-Wyeth merger
  • 10/5/2009UICC establishes China Liason Office in Tianjin
  • 10/5/2009Sinovac receives second order for H1N1 vaccine from the Chinese govern...
  • 10/5/2009Chinese delegation visit Cambridge to forge natural drug research link...
  • 10/5/2009New report: innovative drug R&D on the rise in China
  • 10/5/2009Tianyin Pharma appoints new COO
  • 10/4/2009Nicholas Hall reports continued growth of OTC VMS market in China
  • 10/3/2009Quintiles expects to double its Asian business in five to ten years
  • 9/28/2009Latest developments on China's essential drug policies and implementat...
  • 9/28/2009SFDA seeks public comments on its draft revision to the GMP regulation...
  • 9/28/2009Shenzhen strives to become the largest flu vaccine manufacturing cente...
  • 9/28/2009Chi-Med files another class I anticancer new drug with SFDA
  • 9/28/2009New report predicts skyrocketing medical costs for osteoporosis in Chi...
  • 9/28/2009CEHCA reports sharply rising prevalence of Alzheimer's Disease
  • 9/28/2009TaiGen Biotech reports positive phase I outcome of TG-0054
  • 9/28/2009New report: Chinese breast cancer market to nearly double in five year...
  • 9/28/2009GSK diversifies into energy drinks in China
  • 9/28/2009Novartis eyes AstraZeneca for takeover?
  • 9/28/2009New report: The CRO Market Outlook: Emerging Markets, Leading Players ...
  • 9/28/2009J&J enters monoclonal/vaccine strategic alliance pact with Crucell...
  • 9/28/2009Abbott gets Solvay's pharma business for US$7.6 billion
  • 9/28/2009GSK signs Euro 1.5 billion pneumococcal vaccine deal with Brazil
  • 9/25/2009Experts: China and India to lead in global R&D in two decades
  • 9/25/2009Asymchem opens high potency API and drug product facility in Tianjin ...
  • 9/25/2009Recent executive moves
  • 9/25/2009Nycomed likely to raise its bid for Solvay's drug business unit
  • 9/25/2009BioTime to launch Chinese subsidiary for therapeutic stem cell product...
  • Page:671/800 Total number of articles:23988: [First][<<] [669] [670] [671] [672] [673] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group